Citations

Showing 10 of 108104 citations.

Thermal Ablation of Bone Metastases
Kurup, A. Nicholas , Callstrom, Matthew R. , Moynagh, Michael R., Kurup, Anil N

Mayo Clinic

Seminars in Interventional Radiology | November 5, 2018 | Volume: 35 | Issue: 04 | Pages: 299-308

10.1055/s-0038-1673422 | PMID 30402013 Get It

AbstractImage-guided, minimally invasive, percutaneous thermal ablation of bone metastases has unique advantages compared with surgery or radiation therapy. Thermal ablation of osseous metastases may result in significant pain palliation, prevention of skeletal-related events, and durable local tumor control. This article will describe current thermal ablation techniques utilized to treat bone metastases, summarize contemporary evidence supporting such thermal ablation treatments, and outline an approach to percutaneous ablative treatment.
Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review
Lawton, Andrew J. , Lee, Kathleen A., Ferrone, Marco , Rades, Dirk , Abrahm, Janet L. , Cheville, Andrea , Balboni, Tracy Anne

Mayo Clinic

Journal of Clinical Oncology | November 5, 2018 | Volume: 37 | Issue: 1 | Pages: 61-71

10.1200/jco.2018.78.1211 | PMID 30395488 Get It

PurposeMetastatic spinal cord compression (MSCC) can be a catastrophic manifestation of advanced cancer that causes immobilizing pain and significant neurologic impairment. Oncologists can protect their patients by having a high index of suspicion for MSCC when patients present with new or worsening back pain before motor, sensory, bowel, or bladder deficits develop. We provide an updated, evidence-based narrative review of the presentation, diagnosis, and treatment of MSCC.MethodsThis narrative review was conducted by searching MEDLINE and Cochrane Database of Systematic Reviews for relevant literature on the presentation, diagnosis, and treatment of patients with MSCC. The article addresses the key elements of MSCC management germane to the medical oncologist, with special attention given to pain and symptom management, decision making with regard to surgery and radiation therapy, the importance of rehabilitative care, and the value of a multidisciplinary approach.ResultsMagnetic resonance imaging of the entire spine is recommended for the diagnosis of MSCC. Treatment includes glucocorticoid therapy, pain management, radiation therapy with or without surgery, and specialized rehabilitation. When formulating a treatment plan, clinicians should consider the patient’s care goals and psychosocial needs.ConclusionPrompt diagnosis and treatment of MSCC can reduce pain and prevent irreversible functional loss. Regular collaboration among multidisciplinary providers may streamline care and enhance achievement of treatment goals.
The Endogenous Opioid System: Role and Dysfunction Caused by Opioid Therapy
Toubia, Tarek , Khalife, Tarek

Mayo Clinic

Clinical Obstetrics & Gynecology | November 5, 2018 | Volume: 62 | Issue: 1 | Pages: 3-10

10.1097/grf.0000000000000409 | PMID 30398979 Get It

The endogenous opioid system is comprised of a wide array of receptors and ligands that are present throughout the central and peripheral nervous system, the gastrointestinal tract, and the immune system. This explains the multitude of physiological functions it is responsible for including analgesia, mood regulation, and modulation of the stress response. It also plays a pivotal role in modulating the brain’s reward center with behavioral and social implications on mood disorders and addiction. Exogenous opioid therapy hijacks the endogenous system and alters its functions contributing to an imbalance that is responsible for the pathogenesis of several disease states.
A Cross-Sectional Survey of the North American Skull Base Society Part 3: The State of Lateral Skull Base Surgery Training in North America
Patel, Neil , Tombers, Nicole M. , Link, Michael J. , Carlson, Matthew L. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | November 5, 2018 | Volume: 80 | Issue: 04 | Pages: 399-415

10.1055/s-0038-1675557 | PMID 31316886 Get It

Introduction Optimal management of vestibular schwannoma (VS) demands involvement of an experienced multidisciplinary team. As the number of training programs in neurotology and skull base neurosurgery continues to rise, ensuring that trainees are capable of evidence-based decision-making and treatment, whether microsurgical or radiosurgical, is of paramount importance. The purpose of this study is to characterize the landscape of neurotologic and neurosurgical fellowship training programs in North America, with special reference to VS management. Methods A 64-item web-based survey assessing VS practice trends was devised by members of the North American Skull Base Society (NASBS) Research Task Force and distributed electronically to NASBS membership via SurveyMonkey as a cross-sectional study. Participation was entirely voluntary and there was no remuneration for survey completion. The survey link was active from November 29 to December 14, 2016. Results Of 719 members of the NASBS who were emailed a survey link, a total of 57 were returned (8%) completed surveys. Of all respondents, 51 (89%) claimed to have formal training in skull base neurosurgery or neurotology. Thirty-three respondents (65%) were skull base neurosurgeons while the remainder were neurotologists (n = 18; 35%). Institutions with fellowship programs tended to have a higher surgical, radiosurgical, and overall case volume than those with a residency program alone. However, 20% of respondents at institutions with fellowship programs reported evaluating less than 50 new diagnoses of VS per year and 12% reported a surgical case volume of less than 10 cases per year. Conclusion As the number of skull base training programs expands, it is our duty to ensure that trainees gain sufficient experience to enter independent practice with the ability to exercise informed decision-making and safely perform VS surgery and radiosurgery. In the current training climate, implementing multidisciplinary care models, formalized training requirements, and emerging surgical simulators will support the development of minimum proficiencies in VS care.
Towards Team-Centered Informatics: Accelerating Innovation in Multidisciplinary Scientific Teams Through Visual Analytics
Visweswaran, Shyam , Divekar, Rohit , Brasier, Allan R. , Bhavnani, Suresh K.

Mayo Clinic

The Journal of Applied Behavioral Science | November 5, 2018 | Volume: 55 | Issue: 1 | Pages: 50-72

10.1177/0021886318794606 Get It

A critical goal of multidisciplinary scientific teams is to integrate knowledge from diverse disciplines for the purpose of developing novel insights and innovations. For example, multidisciplinary translational teams (MTTs) which typically include physicians, biologists, statisticians, and informaticians, aim to integrate biological and clinical knowledge leading to innovations for improving health outcomes. However, such teams face numerous barriers in integrating multidisciplinary knowledge, which is further exacerbated by the explosion of molecular and clinical data generated from millions of patients. Here, we explore the use of a visual analytical representation to help MTTs integrate molecular and clinical data with the goal of accelerating translational insights. The results suggest that the visual analytical representation functioned as a “computational evolving boundary object” which (a) evolved through several emergent states that progressively helped integrate diverse disciplinary knowledge, (b) enabled team members to play primary and supportive roles in evolving the data representation resulting in a more egalitarian team structure, and (c) enabled the team to arrive at novel translational insights leading to domain and methodology publications. However, the interventions also revealed limitations in the approach motivating new visual analytical approaches. These results suggest (a) implications for theory related to modeling computational evolving boundary objects (CEBOs) as an instance of team-centered informatics, and (b) implications for practice related to the design and use of interactive features that enable teams to fluidly evolve CEBOs through emergent states, with the goal of deriving novel insights from large multiomics datasets.
Obese Patients Benefit, but do not Fare as Well as Nonobese Patients, Following Lumbar Spondylolisthesis Surgery: An Analysis of the Quality Outcomes Database
Chan, Andrew K. , Bisson, Erica F. , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Potts, Eric A. , Shaffrey, Christopher I. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S, Kerezoudis, Panagiotis, DiGiorgio, Anthony M. , Haid, Regis W., Mummaneni, Praveen V. , Virk, Michael S, Kerezoudis, Panagiotis

Mayo Clinic

Neurosurgery | November 5, 2018 | Volume: 86 | Issue: 1 | Pages: 80-87

10.1093/neuros/nyy589 | PMID 30541141 Get It

Abstract BACKGROUND Given recent differing findings following 2 randomized clinical trials on degenerative lumbar spondylolisthesis (DLS) surgery, there is a need to better define how subsets of patients fare following surgery. OBJECTIVE To investigate the impact of obesity on patient-reported outcomes (PROs) following DLS surgery. METHODS A total of 12 high-enrolling sites were queried, and we found 797 patients undergoing surgery for grade 1 DLS. For univariate comparisons, patients were stratified by BMI ≥ 30 kg/m 2 (obese) and < 30 kg/m 2 (nonobese). Baseline, 3-mo, and 12-mo follow-up parameters were collected. PROs included the North American Spine Society satisfaction questionnaire, numeric rating scale (NRS) back pain, NRS leg pain, Oswestry Disability Index (ODI), and EuroQoL-5D (EQ-5D) Questionnaire. RESULTS We identified 382 obese (47.9%) and 415 nonobese patients (52.1%). At baseline, obese patients had worse NRS back pain, NRS leg pain, ODI, and EQ-5D scores ( P < .001, P = .01, P < .001, and P = .02, respectively). Both cohorts improved significantly for back and leg pain, ODI, and EQ-5D at 12 mo ( P < .001). At 12 mo, similar proportions of obese and nonobese patients responded that surgery met their expectations (62.6% vs 67.4%, P = .24). In multivariate analyses, BMI was independently associated with worse NRS leg pain and EQ-5D at 12 mo ( P = .01 and P < .01, respectively) despite adjusting for baseline differences. CONCLUSION Obesity is associated with inferior leg pain and quality of life—but similar back pain, disability, and satisfaction—12 mo postoperatively. However, obese patients achieve significant improvements in all PRO metrics at 12 mo.
Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network
Herr, Timothy M., Peterson, Josh F. , Rasmussen, Luke V. , Peissig, Peggy , Starren, Justin , Caraballo, Pedro J. , Rasmussen, Luke V , Peterson, Josh F

Mayo Clinic

Journal of the American Medical Informatics Association | November 5, 2018 | Volume: 26 | Issue: 2 | Pages: 143-148

10.1093/jamia/ocy156 | PMID 30590574 Get It

Abstract To better understand the real-world effects of pharmacogenomic (PGx) alerts, this study aimed to characterize alert design within the eMERGE Network, and to establish a method for sharing PGx alert response data for aggregate analysis. Seven eMERGE sites submitted design details and established an alert logging data dictionary. Six sites participated in a pilot study, sharing alert response data from their electronic health record systems. PGx alert design varied, with some consensus around the use of active, post-test alerts to convey Clinical Pharmacogenetics Implementation Consortium recommendations. Sites successfully shared response data, with wide variation in acceptance and follow rates. Results reflect the lack of standardization in PGx alert design. Standards and/or larger studies will be necessary to fully understand PGx impact. This study demonstrated a method for sharing PGx alert response data and established that variation in system design is a significant barrier for multi-site analyses.
T4 extension alone is more predictive of better survival than a tumour size >7 cm for resected T4N0–1M0 non-small-cell lung cancer†
Li, Qiuyuan , Zhang, Peng , Luo, Lei , Diasio, Robert B. , Jiang, Gening , Wang, Yi , Liu, Dan , Yang, Ping

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | November 5, 2018 | Volume: 55 | Issue: 4 | Pages: 682-690

10.1093/ejcts/ezy360 | PMID 30508081 Get It

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Chhabra, Saurabh , Ahn, Kwang Woo , Hu, Zhen‐Huan , Jain, Sandeep , Černý, Jan , Copelan, Edward A. , Daly, Andrew , DeFilipp, Zachariah , Gadalla, Shahinaz M. , Ganguly, Siddhartha , Hamilton, Betty K. , Hildebrandt, Gerhard , Hsu, Jack W., Inamoto, Yoshihiro , Kanate, Abraham S. , Khoury, H. Jean, Litzow, Mark R. , Nathan, Sunita , Olsson, Richard F. , Pawarode, Attaphol , Ringdén, Olle , Rowe, Jacob M. , Saad, Ayman , Schouten, Harry C. , Seo, Sachiko , Shah, Nirav N. , Solh, Melhem , Üstün, Celalettin , Woolfrey, Ann E. , Alyea, Edwin P. , Kalaycio, Matt, Sobecks, Ronald , Saber, Wael , Cerny, Jan , Gadalla, Shahinaz M , Nathan, Sunita , Saad, Ayman , Olsson, Richard F , Ringden, Olov , Chhabra, Saurabh , Assal, Amer , Gale, Robert Peter , Lazarus, Hillard M. , Savani, Bipin N. , Stuart, Robert K. , Yared, Jean A. , Popat, Uday R

Mayo Clinic

Blood Advances | November 5, 2018 | Volume: 2 | Issue: 21 | Pages: 2922-2936

10.1182/bloodadvances.2018024844 | PMID 30396912 Get It

Abstract Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment of chronic myeloid leukemia (CML). Optimal conditioning intensity for allo-HCT for CML in the era of tyrosine kinase inhibitors (TKIs) is unknown. Using the Center for International Blood and Marrow Transplant Research database, we sought to determine whether reduced-intensity/nonmyeloablative conditioning (RIC) allo-HCT and myeloablative conditioning (MAC) result in similar outcomes in CML patients. We evaluated 1395 CML allo-HCT recipients between the ages of 18 and 60 years. The disease status at transplant was divided into the following categories: chronic phase 1, chronic phase 2 or greater, and accelerated phase. Patients in blast phase at transplant and alternative donor transplants were excluded. The primary outcome was overall survival (OS) after allo-HCT. MAC (n = 1204) and RIC allo-HCT recipients (n = 191) from 2007 to 2014 were included. Patient, disease, and transplantation characteristics were similar, with a few exceptions. Multivariable analysis showed no significant difference in OS between MAC and RIC groups. In addition, leukemia-free survival and nonrelapse mortality did not differ significantly between the 2 groups. Compared with MAC, the RIC group had a higher risk of early relapse after allo-HCT (hazard ratio [HR], 1.85; P = .001). The cumulative incidence of chronic graft-versus-host disease (cGVHD) was lower with RIC than with MAC (HR, 0.77; P = .02). RIC provides similar survival and lower cGVHD compared with MAC and therefore may be a reasonable alternative to MAC for CML patients in the TKI era.
RARE-13. CHARACTERIZATION OF ADULT MEDULLOBLASTOMA PATIENTS AT RECURRENCE: RETROSPECTIVE REVIEW OF THE MD ANDERSON CANCER CENTER EXPERIENCE
Mastall, Max , Majd, Nazanin , Gule-Monroe, Maria , Khatua, Soumen , Rao, Ganesh , Sandberg, David I. , Zaky, Wafik , Mahajan, Anita , Suki, Dima , Alfaro, Kristin D, Weathers, Shiao‐Pei , Harrison, Rebecca , Penas‐Prado, Marta, Fuller, Gregory N. , Huse, Jason T. , Wefel, Jeffrey S. , Yeboa, D.N. , Puduvalli, Vinay K. , Harrison, Rebecca, Groot, John de , Peñas-Prado, Marta

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi239-vi239

10.1093/neuonc/noy148.989 Get It